DXCM 53.22 Dexcom Inc $DXCM Hit a 52 week high of 53.62

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
DXCM 53.22 Dexcom Inc $DXCM Hit a 52 week high of 53.62 Closing the day 09:44 at 53.22 -0.41 -0.76% With a day low of 53.18 and a total volume of 53,635.

DXCM Recent Posts: http://investorshangout.com/DexCom-Inc-DXCM-53952/

DXCM Dexcom Inc Recent Headline News

DexCom Scales 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:10PM CST
Impressive third-quarter 2014 results, recent FDA approvals for its new products along with a robust product pipeline contribute to the growth trajectory of DexCom, Inc. (DXCM), creating good momentum for 2015 as well.
ABT: 44.08 (-0.51), JNJ: 108.57 (-0.50), DXCM: 52.69 (-0.94), MDT: 69.09 (-0.29)

DexCom G4 Platinum Software Gains FDA Nod, Shares Surge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:54PM CST
Following the announcement, shares of DexCom, Inc. (DXCM) shot up nearly 14.12% to close at $50.93 in the last trading session.
ABT: 44.08 (-0.51), JNJ: 108.57 (-0.50), DXCM: 52.69 (-0.94), MDT: 69.09 (-0.29)

DexCom Has Returned 17.2% Since SmarTrend Recommendation (DXCM)
Comtex SmarTrend(R) - Mon Nov 10, 9:32AM CST
SmarTrend identified an Uptrend for DexCom (NASDAQ XCM) on October 21st, 2014 at $43.32. In approximately 3 weeks, DexCom has returned 17.21% as of today's recent price of $50.77.
DXCM: 52.69 (-0.94)

Strength Seen in DexCom (DXCM): Stocks Gains 14.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:46AM CST
DexCom (DXCM) was a big mover last session, with shares rising over 14% on the day.
ABMD: 33.12 (-0.36), DXCM: 52.69 (-0.94), EW: 124.48 (-0.07), ANGO: 16.72 (-0.14)

Hologic Beats Q4 Earnings, Sales as All Segments Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 1:50PM CST
Hologic (HOLX) entered into an amended license agreement with Roka Bioscience, which earned a one-time revenue benefit of $20.1 million for Hologic
ABMD: 33.12 (-0.36), DXCM: 52.69 (-0.94), ANGO: 16.72 (-0.14), HOLX: 26.46 (-0.06)

Watch Out: Barbarians At The Gate For DexCom (DXCM)
at The Street - Fri Nov 07, 8:55AM CST
Trade-Ideas LLC identified DexCom (DXCM) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
DXCM: 52.69 (-0.94)

Foundation Medicine Slumps: FMI Tumbles 9.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:59AM CST
Foundation Medicine has been witnessing a flat trend in its current year earnings estimate and its share price has been falling for past 24 hours
ABMD: 33.12 (-0.36), DXCM: 52.69 (-0.94), FMI: 24.76 (-0.19), ANGO: 16.72 (-0.14)

DexCom's (DXCM) CEO Terry Gregg on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 9:13PM CST

DXCM: 52.69 (-0.94)

DexCom misses by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:09PM CST

DXCM: 52.69 (-0.94)

DexCom (DXCM) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:25PM CST

DXCM: 52.69 (-0.94)

DexCom, Inc. Reports Third Quarter 2014 Financial Results
Business Wire - Thu Nov 06, 3:02PM CST
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended September 30, 2014.
DXCM: 52.69 (-0.94)

FDA Approves Dexcom Software with Artificial Pancreas Algorithm
Business Wire - Thu Nov 06, 7:30AM CST
Dexcom, Inc., (NASDAQ XCM), a leader in continuous glucose monitoring (CGM), announced today that the U.S. Food and Drug Administration (FDA) has approved new software for the Dexcom G4(R) PLATINUM CGM. The new Software 505 features the same advanced algorithm as used in artificial pancreas research around the world. The software will impact the performance of the Dexcom G4 PLATINUM, already considered the most accurate CGM system on the market today. The software will be made available free of charge to adult patients using the Dexcom G4 PLATINUM.
DXCM: 52.69 (-0.94)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:35PM CST

BEBE: 2.49 (+0.10), ACET: 21.22 (-0.07), ANET: 77.25 (+0.28), FNGN: 32.35 (-0.01), CPST: 0.91 (-0.03), AUQ: 3.63 (+0.12), AMRN: 0.94 (-0.01), ED: 62.30 (+0.30), ENV: 54.22 (+0.11), FXCM: 16.64 (+0.04), BCEI: 37.95 (-0.16), GXP: 26.51 (+0.08), EAC: 12.36 (-0.07), DXCM: 52.69 (-0.94), CSC: 61.66 (-0.01), AEL: 27.32 (+0.21), HNSN: 0.78 (-0.02), CFN: 57.59 (+0.03), ANAC: 30.70 (-0.76), DAR: 18.69 (-0.01), GST: 3.81 (-0.06), ARC: 9.71 (-0.17), FIVN: 4.91 (-0.03), ELON: 1.91 (-0.01), FSLR: 47.62 (+0.06), EZPW: 11.12 (-0.06), ALIM: 5.19 (+0.02), FWM: 2.25 (-0.05), BRS: 70.48 (-0.66), ECOM: 18.74 (-0.16), FTEK: 3.86 (-0.04), CVT: 28.36 (+0.11), AL: 37.02 (+0.08), BBRG: 13.27 (+0.10), BPZ: 0.91 (-0.03), ECPG: 44.84 (-0.39), HTGC: 15.59 (+0.07), AIRM: 44.20 (+0.21), BNFT: 25.14 (-0.90), ENOC: 14.86 (+0.07), HPTX: 21.42 (-0.17), AGO: 24.91 (+0.05), FICO: 71.92 (+0.11), FF: 12.15 (-0.03), FI: 20.12 (+0.10), EVC: 5.36 (+0.12), EBS: 24.16 (-0.16), ABCO: 46.22 (unch), DIOD: 25.96 (+0.19), DIS: 90.75 (+0.26), EGOV: 17.51 (+0.22), APEI: 36.69 (+0.84), DVA: 77.36 (+0.32), CLVS: 55.69 (-1.11), HCI: 42.54 (+0.74), BRKR: 18.08 (-0.22), HGR: 21.20 (-0.04)

DexCom Announces Upcoming Conference Presentations
Business Wire - Thu Oct 30, 7:30AM CDT
DexCom, Inc. (NASDAQ XCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:
DXCM: 52.69 (-0.94)

Forget MannKind Corporation: 3 Better Stocks
Motley Fool Staff - Motley Fool - Mon Oct 27, 8:13AM CDT
Source: MannKind. A doubling of Americans diagnosed with diabetes over the coming decade may support demand for  MannKind 's inhalable insulin Afrezza, but that doesn't necessarily mean that MannKind is biotech's best idea. We asked three of...
DXCM: 52.69 (-0.94), NVAX: 5.17 (-0.02), AGIO: 83.67 (-2.82), SNY: 46.44 (-0.09), MNKD: 6.16 (-0.02), CELG: 103.71 (-3.72)

DexCom reports November 6
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 9:43AM CDT

DXCM: 52.69 (-0.94)

DexCom Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 at 4:30 p.m. Eastern Time
Business Wire - Thu Oct 23, 7:31AM CDT
DexCom, Inc. (NASDAQ XCM) today announced that it plans to release its third quarter 2014 financial results after market close on Thursday, November 6, 2014. Management will hold a conference call to review the company's third quarter 2014 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to "Our Company," then "Investor Relations," and then "Events and Webcasts," and will be archived there for future reference.
DXCM: 52.69 (-0.94)

FDA Approves Dexcom SHARE(TM), the First Remote Mobile Communications Device Used for Continuous Glucose Monitoring (CGM)
Business Wire - Mon Oct 20, 8:24AM CDT
Dexcom, Inc. (NASDAQ XCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE. Dexcom SHARE, an accessory to the Dexcom G4(R) PLATINUM Continuous Glucose Monitoring System, uses a secure wireless connection to transmit the glucose levels of a person with diabetes to the smartphones of up to five designated recipients, or "followers." These followers can remotely monitor a patient's glucose information and receive alert notifications from almost anywhere via their Apple(R) iPhone(R) or iPod(R) touch. With Dexcom SHARE, parents and personal caregivers can monitor a child's or loved one's glucose data from a remote location, giving them peace of mind and reassurance when they are apart.
DXCM: 52.69 (-0.94)

MFG, PGTI, MWIV, BKD, AREX, DXCM Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Oct 06, 6:29AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Mizuho Financial Group Inc (NYSE:MFG), PGT Inc (NASDAQ GTI), MWI Veterinary Supply Inc (NASDAQ:MWIV), BROOKDALE SENIOR LIVING INC. (NYSE:BKD), Approach Resources Inc (NASDAQ:AREX), DexCom Inc (NASDAQ XCM) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
MFG: 3.52 (-0.05), DXCM: 52.69 (-0.94), MWIV: 157.96 (+0.08), PGTI: 9.59 (-0.10), BKD: 33.27 (+0.20), AREX: 12.07 (+0.61)

The Stunning Mobile Game Changer for Diabetics That Investors Can't Ignore
Leo Sun, The Motley Fool - Motley Fool - Sun Oct 05, 8:31AM CDT
Ever since Apple launched the first iPhone nearly seven years ago, developers have released mobile apps and connected devices to improve the lives of diabetes patients. These products helped diabetics track meals, insulin dosages, glucose...
JNJ: 108.57 (-0.50), DXCM: 52.69 (-0.94), MDT: 69.09 (-0.29), SNY: 46.44 (-0.09), AAPL: 113.94 (+1.12)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AWK Adds Fayette Water System With $9M Upgrade Plan

Updated Category News Views 89

Small water systems do not usually collapse in one dramatic heap; they get worn down by scattered pipes, compliance demands, thin staffing and bills nobody wants to raise. That is the backdrop for Pennsylvania American Water’s completed $32.8 million purchase of the Indian Creek Valley Water Authority system. For American Water shareholders, this is the familiar...

Continue Reading
Yoodli's No. 9 Ranking Signals Enterprise AI Traction

Updated Category News Views 96

Ninth place can be easy to dismiss until you notice the company is sitting near the top of a 500-name growth list. Yoodli's No. 9 position on Deloitte's 2026 Technology Fast 500 is a meaningful signal that its AI-based coaching and workforce-skills pitch is getting traction inside large organizations. It is not a revenue disclosure, it is not a valuation marker, and...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 150

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 161

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
Frosty Animatronics Put Nostalgia on Lowe's Shelves

Updated Category News Views 114

A moving corncob pipe is not anybody's idea of a macroeconomic signal, yet holiday aisles are built on precisely these little jolts of recognition. Gemmy has teamed with Warner Bros. Discovery Global Consumer Products to place a new animated Frosty the Snowman collection exclusively at Lowe's for the 2026 holiday season. It is cheerful retail business, not earthshaking...

Continue Reading
The Hanover Survey Puts Small-Business Trust on Trial

Updated Category News Views 91

A dark storefront can apparently erase goodwill faster than plenty of owners want to admit. The Hanover Insurance Group's 2026 Small Business Pulse Report found that 60% of surveyed consumers would temporarily buy from a competitor if their preferred small business shut unexpectedly. More than half would start looking elsewhere within a week. That is not a cute...

Continue Reading
Peñoles Locks In Solar Storage for Northern Mine Loads

Updated Category News Views 45

A mine never sleeps, which is why the battery matters more than the solar-panel headline. Peñoles has signed a 20-year power-supply agreement with Atlas Renewable Energy for a Coahuila project combining 269 MWp of solar generation with battery storage. The project is slated to begin operating in the first half of 2029 and is expected to provide roughly 550 GWh a year to...

Continue Reading
Norfolk Southern's 200-Year Campaign Meets a Hard Market

Updated Category News Views 61

Two centuries of railroad history can stir the blood, but it does not move a single carload by itself. Norfolk Southern has opened its 200-year railroading celebration with the GeneratioNS campaign, a three-locomotive NS 200 commemorative series, and plans for public events across its network. For a railroad with deep roots and very modern operational pressures, this is...

Continue Reading
Watson Motion Tests Military Pretrial Confinement Rules

Updated Category News Views 157

Military confinement fights are rarely neat, and this one comes with a short clock but plenty of unanswered questions. Defense lawyers for U.S. Air Force Maj. Jason Watson argued on Nov. 17 that he should be released from pretrial confinement while his case proceeds. A military judge is ordinarily expected to issue a ruling within 14 days of the hearing, under the court's...

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 90

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading

Top 5 Most Recently Viewed Articles

evolv Consulting and Snowflake Join Forces in Automotive Tech

Updated Category News Views 205

evolv Consulting Partners with Snowflake for Automotive Innovation evolv Consulting empowers data-driven insights at scale for the automotive industry through Snowflake AI Data Cloud for Manufacturing. evolv Consulting, recognized as an Elite Snowflake Services partner, has announced a strategic collaboration with Snowflake to enhance the AI Data Cloud for Manufacturing...

Continue Reading
Martela Corporation Shares Decline: Key Updates and Implications

Updated Category News Views 158

Martela Corporation Reports Notable Changes in Shareholding Martela Corporation has recently seen significant transactions that impact its share structure, which is crucial information for investors. On a particular date, Isku-Yhtymä Oy made an important announcement regarding its shareholding in Martela. This report revealed that Isku-Yhtymä Oy had sold enough shares...

Continue Reading
Forecasting Growth in the Chlorine Trifluoride Market by 2032

Updated Category News Views 221

Overview of the Chlorine Trifluoride Market Chlorine trifluoride is emerging as a pivotal player in numerous high-tech applications, with the market anticipated to reach a staggering USD 82.81 million by 2032. This significant growth is fueled by an annual compound growth rate (CAGR) of 4.64% from the previous years. The reactivity of chlorine trifluoride makes it an...

Continue Reading
Ryde Group's Public Offering: Key Insights and Developments

Updated Category News Views 274

Ryde Group Ltd (NYSE American: RYDE) made waves in the market with its public offering valued at approximately $4.5 million. The offering encompassed 5.3 million units, each comprising one Class A Ordinary Share plus a warrant that can be exercised into an additional Ordinary Share at $0.85. With warrants exercisable immediately and valid for five years, traders keen on...

Continue Reading
Citi's Optimistic Forecast for Enel Stock Amid Renewables Growth

Updated Category News Views 145

Citi's Optimistic Outlook on Enel Recently, Citi reaffirmed its strong Buy rating on Enel (BIT: ENEI) SpA stock, maintaining a price target of EUR7.40. This renewed confidence comes ahead of the company's anticipated third-quarter earnings announcement slated for early November. Analysts at Citi predict that Enel is poised to deliver robust financial results, prompting...

Continue Reading